William John Sibold, President and CEO at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 14,101 shares at $400.03 ($5.6M) on 2025-08-21, disclosed to the SEC on 2025-08-21.
Scheduled sale ($5.6M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $400.03 | 6,485 | $2.6M | 46.0% |
| 2 | $400.03 | 6,485 | $2.6M | 46.0% |
| 3 | $401.00 | 1,131 | $454K | 8.0% |
| Total | $400.11 avg | 14,101 | $5.6M | 100% |
| Filing → |
| MDGL | SELL | 2026-03-06 | $718K | — | Filing → |
| MDGL | SELL | 2026-01-26 | $777K | — | Filing → |
| MDGL | SELL | 2025-12-04 | $1.4M | — | Filing → |